Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease
Authors:
- 11 November 2024
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 61 (3) , 481-490
Abstract
Background and Aims: Alcohol use is prevalent among hepatology clinic patients with chronic liver disease (CLD). We explored factors associated with the importance and confidence dimensions of motivation to reduce drinking.Methods: Participants (N = 121) with unhealthy alcohol use (i.e., over NIH guidelines) receiving care in hepatology clinics from a safety‐net hospital (SN, N = 54) and two Veterans Affairs Healthcare Systems (VA, N = 67) were enrolled in an alcohol intervention trial from March 2022 through October 2023. Baseline assessments included Generalised Anxiety Disorder (GAD‐7), Patient Health Questionnaire (PHQ‐8), Alcohol Use Disorders Identification Test (AUDIT), COVID‐19 stress; and measures of importance and confidence to decrease alcohol use (readiness rulers, scales of 1–10). Liver disease aetiology and severity were extracted from electronic health records. We performed multivariable linear regression models with forward selection to assess pre‐specified variables' associations with importance and confidence.Results: The sample was 84% male, 40% Latino, 31% White, 18% Black and 11% other races; median age was 61 years. Median (Q1–Q3) AUDIT score was 16 (12–24), importance was 9 (6–10) and confidence was 8 (5–9). On multivariable analysis, VA site (vs. SN) participants had a 0.97‐point lower importance score (p = 0.02); higher symptoms of depression (PHQ‐8 score ≥ 10 vs. < 10) and AUDIT scores (for each point increase) were associated with higher importance score (estimates 1.2 and 0.08, p < 0.05, respectively). Liver disease aetiology and severity were not significantly associated with outcomes.Conclusions: Depression, alcohol problem severity and treatment site may influence motivation to reduce alcohol use and could inform future hepatology‐based interventions.Keywords
Funding Information
- National Institute on Alcohol Abuse and Alcoholism (R01AA029312, K24AA022523, K24AA025703)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK026743)
This publication has 45 references indexed in Scilit:
- Cross‐sectional study on stigma and motivation to adhere to lifestyle modification among vulnerable populations with fatty liver diseaseObesity Science & Practice, 2023
- Alcohol use disorder in community management of chronic liver diseasesHepatology, 2023
- Psychiatric Disorders and Their Treatment: Impact of Outcomes in Patients With Chronic Liver DiseaseClinical Liver Disease, 2022
- Understanding the Impact of COVID-19 on Latino Sexual Minority Men in a US HIV Hot SpotAIDS and Behavior, 2020
- Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver DiseasesHepatology, 2019
- Factors associated with hazardous alcohol use and motivation to reduce drinking among HIV primary care patients: Baseline findings from the Health & Motivation studyAddictive Behaviors, 2018
- Alcohol-related problems and life satisfaction predict motivation to change among mandated college studentsAddictive Behaviors, 2014
- Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of TransplantationHepatology, 2013
- Alcoholic Liver DiseaseHepatology, 2010
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006